|
Search
Collections
Benchmarks
Upload document
Indication
RP1
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 drug
Clinical trial
A Phase 1B Study of Intralesional Injection of RP1 in Patients With Resectable Cutaneous SCC
Status: Recruiting
, Estimated PCD: 2025-12-01
Drug
RP1
